%D8%A7%D9%84%D8%AC%D9%84%D9%88%D8%A8%D9%8A%D9%88%D9%84%D9%8A%D9%86_%D8%A7%D9%84%D9%85%D9%86%D8%A7%D8%B9%D9%8A_Rho(%D8%AF%D9%8A)Rho(D)_immune_globulinImmunoglobuline_anti-DRho(D)_%D5%AB%D5%B4%D5%B8%D6%82%D5%B6%D5%B8%D5%A3%D5%AC%D5%B8%D5%A2%D5%B8%D6%82%D5%AC%D5%AB%D5%B6%E6%8A%97D%E3%83%92%E3%83%88%E5%85%8D%E7%96%AB%E3%82%B0%E3%83%AD%E3%83%96%E3%83%AA%E3%83%B3%E0%AC%86%E0%AC%B0%E0%AC%8F%E0%AC%9A%E0%AC%93_(%E0%AC%A1%E0%AC%BF)_%E0%AC%87%E0%AC%AE%E0%AD%8D%E0%AC%AE%E0%AD%8D%E0%AD%9F%E0%AD%81%E0%AC%A8_%E0%AC%97%E0%AD%8D%E0%AC%B2%E0%AD%8B%E0%AC%AC%E0%AD%8D%E0%AD%9F%E0%AD%81%E0%AC%B2%E0%AC%BF%E0%AC%A8Immunoglobulina_anty%E2%80%93Rh0_(D)%E0%B8%AD%E0%B8%B4%E0%B8%A1%E0%B8%A1%E0%B8%B9%E0%B9%82%E0%B8%99%E0%B9%82%E0%B8%81%E0%B8%A5%E0%B8%9A%E0%B8%B8%E0%B8%A5%E0%B8%B4%E0%B8%99%E0%B8%95%E0%B9%88%E0%B8%AD_Rho(D)Globulin_mi%E1%BB%85n_d%E1%BB%8Bch_Rho(D)Q3149137
about
Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)Safety, Tolerability, Efficacy, and Pharmacokinetic Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy SubjectsIntravenous Immune Globulin to Treat Hereditary Inclusion Body MyopathyBelatacept in Kidney Transplantation of Moderately Sensitized PatientsNevirapine Study for the Prevention of Maternal-Infant HIV Transmission in UgandaSafety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric SubjectsClinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in AdultsStudy of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement TherapySafety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human SerumPharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary ImmunodeficiencyMulticenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)IVIG Treatment for Asthmatic Patients With IgG Subclass DeficiencyBioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency DiseasesIntravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive TractIGIV Study for Chronic ITP Patients Ages 3-70A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)Intravenous Immunoglobulin Therapy in Optic NeuritisComparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMRReal-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionKIDCARE (Kawasaki Disease Comparative Effectiveness Trial)A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated MyelopathyA Study to Evaluate Albumin and Immunoglobulin in Alzheimer's DiseasePhase 3 IGIV, 10% in Alzheimer´s DiseaseEvaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic GanglionopathyIntravenous Immunoglobulins for Post-Polio SyndromePilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver TransplantationSafety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar AtaxiaIntravenous Immunoglobulins in Severe and Refractory Solar UrticariaStudy of Intravenous Immunoglobulin in Amnestic Mild Cognitive ImpairmentHepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)Autologous Stem Cell Transplantation in Patients With Systemic SclerosisHepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BIVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China HospitalImmune Globulin Subcutaenous (Human), 20%Minipooled-IVIG in Primary Immunodeficiency Disease
P4844
Q61862200-7CFEF88B-C65A-4C64-9037-BA1F1548FF56Q61864712-A91BC01B-15CA-47C5-9437-CB083AA63DB8Q61864759-4D87B13C-90A0-4BC5-A43D-E284BFB6DCB3Q61865281-AB06A1B4-F6FC-4922-9C03-582EC9D08A2AQ61894370-76D88AC2-4D9F-42D2-ADDD-2B4D39FFB138Q61914979-D817EBD6-1D8B-49F7-91A1-D744417B9145Q61915496-2CF7FBEB-C61C-4A5C-86D5-7FC3D14B227AQ61921445-18E96819-9F57-46A6-B7A9-FEC569D0783FQ61922087-97F044E3-C4E2-473A-8670-A351E3A10394Q61923861-E9DFE77F-72E6-4E88-80DA-97913790B640Q61956449-4EB1454B-FFE9-4D43-BFDD-5F319566253EQ61957312-A5A2F1E5-4835-4E8F-9E5A-D4863FBE4E66Q61965902-2AB069E3-A9BD-4EF4-B911-B2791DB9E4EAQ61969950-B2EC9C4F-D951-4314-9186-5F0B73AA5A7BQ61975950-6D34096E-AF78-43FA-9DEC-B3657C9C0C31Q61979133-F664D30C-2585-44AE-88AF-D75D294FB508Q61979138-AB60EC44-275B-4B58-867D-0E73A884B172Q61980105-6C3BFE68-91B1-4F88-9F9A-14C0951F5130Q62030773-6E7D69A0-869F-46AB-9E5F-BA5975AA075BQ62035427-70E991B8-490B-4703-BEC5-50826C61FA89Q62040713-7FEC9880-DF20-4085-A426-726F9CE842CCQ62105805-442561E4-316F-41B4-91E3-CFD37C090DB9Q63229551-BD3378A2-2814-4EAE-911B-C92387B66D2EQ63316328-DD62ED07-E04E-4066-966C-E7259B7D6A19Q63316495-456D0976-EAFC-474E-95EF-6E8871AFD081Q63319107-77941E1A-1D27-4E5F-B45B-0EE554A170F6Q63319871-B6185727-7455-404F-9FDF-F4E7C4AE98B4Q63320002-3D5401DE-0C71-4B4F-9921-F51796F03BE5Q63322132-90735933-9864-4485-B36F-63ADE8BE8D95Q63334812-7B4DA1FB-F43F-4470-8CF8-A89DCD21C7F6Q63335398-16189952-D538-4E61-92DB-4198CD7339B2Q63338097-E84680DF-415D-4D8D-AB43-C1F9AEDD2126Q63339117-4AAD9E55-3690-49AC-A50B-87F92B763EFCQ63339190-B6A39329-44AF-4AAC-B149-99D0A7391AC7Q63395024-FC1EB7BA-1634-44AA-837D-89ED588E369BQ63396912-40447969-2CDB-45F1-A1FA-E2F8046F9DDEQ63405619-F31336EA-AE14-4ACB-A219-BC91A276FE2EQ63534675-3669481D-4C4E-4A9E-9489-F77E290F2439Q63576219-35B51D74-A5FA-44E5-BD78-D6CB7E92EF96Q63580117-90223211-6B93-4266-8C27-BE40193CDAFD
P4844
description
Rhマイナスの母親とRhプラスの特発性血小板減少性紫斑病(ITP)の患者に投与される薬剤
@ja
medication used to prevent RhD isoimmunization
@en
surowica zawierająca głównie I ...... owi Rh(D) ludzkich erytrocytów
@pl
name
Globulin miễn dịch Rho(D)
@vi
Immunoglobulina anty–Rh0
@pl
Immunoglobuline anti-D
@fr
Rho(D) immune globulin
@en
Rho(D) իմունոգլոբուլին
@hy
rogam
@ta
ανοσοσφαιρίνη αντι-D
@el
الجلوبيولين المناعي Rho(دي)
@ar
ଆରଏଚଓ (ଡି) ଇମ୍ମ୍ୟୁନ ଗ୍ଲୋବ୍ୟୁଲିନ
@or
อิมมูโนโกลบุลินต่อ Rho(D)
@th
type
label
Globulin miễn dịch Rho(D)
@vi
Immunoglobulina anty–Rh0
@pl
Immunoglobuline anti-D
@fr
Rho(D) immune globulin
@en
Rho(D) իմունոգլոբուլին
@hy
rogam
@ta
ανοσοσφαιρίνη αντι-D
@el
الجلوبيولين المناعي Rho(دي)
@ar
ଆରଏଚଓ (ଡି) ଇମ୍ମ୍ୟୁନ ଗ୍ଲୋବ୍ୟୁଲିନ
@or
อิมมูโนโกลบุลินต่อ Rho(D)
@th
altLabel
Immunoglobuline Anti-D
@fr
Immunoglobuline anti-Rho (D)
@fr
Immunoglobuline anti-d
@fr
Rhogam
@fr
Rhophylac
@fr
Rho(D)免疫球蛋白
@zh
prefLabel
Globulin miễn dịch Rho(D)
@vi
Immunoglobulina anty–Rh0
@pl
Immunoglobuline anti-D
@fr
Rho(D) immune globulin
@en
Rho(D) իմունոգլոբուլին
@hy
rogam
@ta
ανοσοσφαιρίνη αντι-D
@el
الجلوبيولين المناعي Rho(دي)
@ar
ଆରଏଚଓ (ଡି) ଇମ୍ମ୍ୟୁନ ଗ୍ଲୋବ୍ୟୁଲିନ
@or
อิมมูโนโกลบุลินต่อ Rho(D)
@th
P672
P486
P6366
P672
P1417
science/Rho-GAM
topic/Rho-D-immune-globulin
P1461
anti-d-rho-immunoglobulin
P2868
P486
P6366
2777115595
P672
D12.776.124.486.485.114.619.393.700
D12.776.124.790.651.114.619.393.700
D12.776.377.715.548.114.619.393.700